Published May 16, 1983
| Version v1
Patent
Open
Imaging tumors with radiolabelled monoclonal antibodies
Description
Using a metallic radionuclide, either directly bound to a monoclonal antibody, or to a chelating agent (such as di-ethylenetriamine-pentaacetic acid (DTPA)) conjugated to the antibody, a tumor can be traced rapidly and with high specificity. The labelled antibody is injected into the host. In some cases, a localization of distant metastases is possible, giving an indication of tumor spreading. Detection occurs by photoscanning. (Auth.)
Availability note (English)
MF available from INIS under the Report Number.Files
14806531.pdf
Files
(972.4 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:12507dab241ee1c8205795c4d6ceaa4e
|
972.4 kB | Preview Download |
Additional details
Additional titles
- Original title (Dutch)
- In beeld brengen van tumor met radioactief gemerkte monoclonale antilichamen
Publishing Information
- Imprint Pagination
- 29 p.
- IPC:
- Int. Cl. A61k49/02; G01n33/56.
- IPC
- Int. Cl. A61k49/02; G01n33/56.
- Patent number
- NL patent document 8204108/A/
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- Netherlands
- INIS RN
- 14806531
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- LABELLING; METASTASES; MONOCLONAL ANTIBODIES; NEOPLASMS; RADIOISOTOPE SCANNING; TRACER TECHNIQUES; TUMOR CELLS
- Descriptors DEC
- ANIMAL CELLS; ANTIBODIES; COUNTING TECHNIQUES; DISEASES; ISOTOPE APPLICATIONS
Optional Information
- Notes
- 4 figs.
- Secondary number(s)
- US priority 315286.